Method for treating a tuberculous prostatitis side effect caused by BCG perfusion therapy for bladder cancer
US11324790B2 · kind B2 · utility
0Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2020 |
| Grant date | May 10, 2022 |
| Priority date | — |
| Expiry date | Aug 18, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K36/8945
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a side effect caused by bacillus Calmette-Guérin (BCG) perfusion therapy for bladder cancer includes: administering a Chinese medicine composition to a subject in need thereof; wherein, the Chinese medicine composition is an extract of a first mixture comprising Rhizoma anemarrhenae, Cortex phellodendri, Glycyrrhiza uralensis, Rehmanniae Radix, Fructus corni, Rhizoma dioscoreae, Poria, Moutan cortex, Rhizoma Alismatis, Radix achyranthis bidentatae, and Atractylodes lancea.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.